The CarciScan ecosystem

One QR code per woman.
One connected pathway.

CarciScan is the laboratory assay. Around it, Malaya United connects everyone a screening programme depends on: government and local government units, screening sites, partner laboratories, patient navigators and the cold-chain logistics in between, from the day a woman registers to the day her result is acted on.

Seven parties around one patient record. The Malaya Operations Platform is operated by Malaya United.

Follow the journey. Understand the purpose.

Five stations every woman passes through on her way from a first question to the care she needs. Select a station to see her question, the task our ecosystem is being built to take on there, and why that step matters to our founder.

“A woman deserves more than a test. She deserves a clear path to care.” Read the founder's story

1Awareness Why should I get screened?

Her question
“I feel healthy. Why should I get screened, and is it really meant for someone like me?”
What our ecosystem must do
Bring clear, respectful information into the community through local government health units, screening sites and community health workers: what HPV screening is, who it is for and why finding changes early matters.
Why it matters to me
“Prevention starts long before the test, with a woman who feels she has a reason, and a right, to come.”

2Access & Sampling How can I take the first step?

Her question
“Where do I go, how far is it, and what will happen to me there?”
What our ecosystem must do
Offer screening sites close to where women live, a simple registration with a personal patient record and QR code, and a sample collected by a trained clinician with privacy and dignity.
Why it matters to me
“The first step has to be close to home and feel safe. Otherwise many women will never take it.”

3Logistics & Laboratory What happens to my sample?

Her question
“Once my sample leaves the clinic, who takes care of it? Could it get lost?”
What our ecosystem must do
Keep a documented chain of custody from collection through cold-chain transport to a qualified partner laboratory, where the sample is tested with CarciScan by PCR and the laboratory head approves every result.
Why it matters to me
“A sample carries a woman's trust. Every handover on its way to the laboratory has to honour that.”

4Results & Understanding What does my result mean?

Her question
“I have my result. What does it actually mean for me?”
What our ecosystem must do
Deliver results securely and digitally, in plain language, and make clear that a screening result is not a cancer diagnosis: a positive result means further clinical evaluation is needed.
Why it matters to me
“A result she cannot understand is not yet care. Clarity is part of the service.”

5Follow-up & Care What happens next?

Her question
“My result needs follow-up. Where do I go now, and who will help me?”
What our ecosystem must do
Provide structured follow-up: patient navigation that tracks every positive result, refers her to appropriate clinical care and stays with her until the next step is done.
Why it matters to me
“This is the step that decides whether screening protects a life. No woman should be left alone with a positive result.”

Ace John Oliver Vollbrecht

Founder & CEO, Malaya United Trading Inc.

Help us bring this journey to more women.
Who is connected

Screening, laboratory, follow-up and supply on one platform.

The Malaya Operations Platform links every party in the pathway. Each one works in its own view and sees only what its role needs.

Government and LGUs
The Department of Health, local government units and provinces own and fund screening programmes, and follow programme progress and totals for the women enrolled in their own programmes.
Screening sites
Hospitals, rural health units and health centres register women, check them in and collect the cervical sample.
Partner laboratories
Run the CarciScan HPV PCR assay. The laboratory head approves every result before it is released.
Patient navigators
Follow up positive results and track each referral to evaluation and care.
Couriers and cold chain
Take kits out and bring sample bundles in, with two-way scans and temperature records on every shipment.
CarciScan supply
The assay is imported from Türkiye by batch and tracked by batch, expiry date and temperature logger.
The woman
Registers once, receives a personal QR code and sees her result securely online.
Why it matters

Screening only works when every step connects.

Cervical cancer can be prevented when high-risk HPV is found early and followed up. Between a test kit and a woman's result, though, many steps are still fragile.

Illustration: a white cool box with ice packs and sample tubes, the kind of box that carries kits and samples between sites and laboratories.

Many hands, no shared view.

Sites, couriers, laboratories and navigators each hold one part of a woman's journey. Without a common record, the parts do not meet.

  1. Screening sites

    Each site keeps its own patient list.

  2. Couriers

    Handovers go unrecorded, so a missing box leaves no trail.

  3. Laboratories

    Large bundles of tubes are matched to patients by hand.

  4. Navigators

    Positive results can reach them late, or not at all.

How it fits together

One platform, three flows.

We are building the Malaya Operations Platform so that sites, couriers, laboratories and navigators work from the same record. Three flows run through it.

  1. The woman's journey

    One QR code per woman, from registration to her result.

    See the patient pathway
  2. Kits and cold chain

    Every kit tracked by batch, from import to use.

    See the kit supply chain
  3. Follow-up

    Each positive result followed through to care.

    See how follow-up works
AI-generated illustration of the Philippine islands at night, with light arcs connecting communities across the sea.
We want to connect screening across island communities. The routes are illustrative.
Patient and sample pathway

From registration to follow-up, in six recorded steps.

Every sample carries a barcode that links it to the woman, the collector, the time and the kit lot, so it can be traced at each step.

  1. Register

    She can register online on her own phone, with site staff or on paper. We record her privacy consent and issue her personal QR code.

  2. Screening day

    Check-in by QR code. A trained clinician collects the cervical specimen with the CarciScan collection kit.

  3. Label and bundle

    Each tube is labelled by scanning her QR code and the kit batch, then sent to the laboratory in bundles.

  4. Laboratory

    The partner laboratory runs the CarciScan PCR assay and enters each result by tube barcode.

  5. Result release

    After laboratory-head approval the result is released securely online with a PDF report, and she is notified by email and SMS.

  6. Follow-up

    A positive result goes to a patient navigator for referral. Every woman is reminded when it is time to screen again.

Patient app screen: My QR, a personal QR code to show at the screening site, usable without internet. Phone lock screen with a notification: your screening result is ready, sign in to the Malaya United patient app to see it.
The woman's side

Her QR code, her result, on her own phone.

The patient app keeps everything that matters to her in one place, and the notification itself never reveals a result.

  • One QR code for every screening visit, shown at the site, also without internet.
  • A notification that her result is ready, with no health details in the message.
  • Her laboratory report ready to save as a PDF.
  • A reminder when it is time to screen again.

Concept screens of the patient app, shown with sample data.

Privacy by design

Each party sees only what it needs.

One record per woman does not mean one view for everyone. Access follows the role, and every access is logged.

Kit supply and cold chain

From the warehouse to the laboratory, on record.

The same platform tracks the kits: stock by batch and expiry, freezer monitoring, temperature records for every shipment and scans at both ends of each delivery.

  1. Import

    Kits are shipped by batch from Türkiye with a temperature logger.

  2. Receive and release

    The temperature record is checked; each batch is released or held in quarantine.

  3. Store

    Freezer locations with live temperature monitoring and alerts.

  4. Order

    Screening sites order collection kits; laboratories order PCR test kits.

  5. Deliver

    Earliest expiry first, with two-way scans at pickup and drop-off.

  6. Confirm

    The receiver confirms delivery and the order is invoiced.

Concept screen of the partner dashboard. Figures are left blank on purpose: they appear once a programme runs.
Programme oversight

Every programme, visible to the people who run it.

Each partner will follow its own programme as it happens, and we will keep every programme, site and laboratory in view so that problems surface early. The dashboards are being built with the platform.

  • Partner view. LGUs and hospitals follow their own screening events and results.
  • Our view. Every programme, site, laboratory and freezer on one screen.
  • Reports. Programme figures ready to export and share with the programme owner.
Where CarciScan fits

The assay at the centre of the pathway.

CarciScan delivers the laboratory result. The ecosystem makes sure the sample reaches a qualified laboratory and the result reaches the woman and her clinician.

  • CoverageAll 14 high-risk HPV types; HPV 16, 18 and 45 reported individually, the other 11 in three pooled results.
  • SpecimenClinician-collected cervical specimen in CarciScan Viral Transport Medium.
  • Specimen stability2 to 30 °C for up to 72 hours; −20 °C if extraction is delayed.
  • Built-in controlA human internal control (RNase P) in every sample.
  • Intended useA screening test for professional laboratory use, not a stand-alone diagnosis.
Full specifications and clinical evidence →
Who owns which step
CarciScanCollection materials, extraction chemistry and the PCR assay behind the result.
LaboratoryProcessing on its validated PCR instrument, quality control, result review and release.
Healthcare providerEligibility, clinical interpretation, referral and treatment.
Malaya UnitedCoordination, supply, cold-chain logistics, laboratory onboarding and training, and the digital platform that connects every step.
Who it serves

Built for the people who run screening, and the women it is for.

DOH, LGUs and city health offices

One portal for programmes, screening events, kit orders and reports, with programme totals for their own population.

Partner laboratories

Incoming sample bundles with count and temperature checks, result entry by tube barcode, approval by the laboratory head, reliable kit supply and onboarding support.

Screening sites

Hospitals, rural health units and barangay health centres: QR check-in, labelled tubes, sample bundles and kit stock, also where the signal is weak.

30–65

Women aged 30 to 65

The age group for HPV DNA screening in the Philippine HTA Council recommendation. One QR code for every visit, a secure result she can save as a PDF, a navigator when a result needs follow-up, and a reminder when it is time to screen again.

For a cervical-cancer-free Philippines.

That is the goal we work towards: every woman reached, every sample on record, every result back to her, and every positive result followed through to care.

Live now
We offer online registration and navigator follow-up, from a positive result through referral to care.
Complete the workflow
We are bringing registration, samples, laboratories, warehouse and cold chain into one connected operations platform.
Scale up
We plan to add mobile apps, connect more laboratories and reach new regions.
AI-generated coastal-community illustration with palm trees, homes and boats beside a calm bay, with green hills beyond.
We want screening to reach women where they live, from cities to coastal communities. Illustration.

Building a screening programme?

Programme owners, laboratories and screening sites can reach the Malaya United team directly.